Skip to content

Observational Study of Choline, Its Metabolites, and Phospholipids in Preterm Infants

Supply of Term and Preterm Neonates With Choline, Lipids and Vitamines

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02027584
Acronym
NEO-CHOLIN
Enrollment
414
Registered
2014-01-06
Start date
2008-11-30
Completion date
2013-07-31
Last updated
2014-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prematurity

Keywords

infant, premature, infant, newborn, choline

Brief summary

To study concentrations of choline, its metabolites, and phospholipids in cord blood and remnants of clinically indicated blood samples

Detailed description

To collect cord plasma in preterm and term infants. To collect remnants of clinically indicated blood samples in parturients and hospitalized preterm infants during neonatal intensive care. To determine concentrations of choline, its metabolites, and phospholipids by mass spectrometry. To compare cord plasma concentrations with postnatal plasma concentrations.

Interventions

OTHERcollection of remnant of clinically indicated blood sample

collection of remnant of clinically indicated blood sample

Sponsors

Universität Tübingen
CollaboratorOTHER
University Hospital Tuebingen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 6 Months
Healthy volunteers
Yes

Inclusion criteria

* meeting criteria of the 4 cohorts

Exclusion criteria

* none pre-defined

Design outcomes

Primary

MeasureTime frame
Concentration of choline in plasmaat times when a clinically indicated blood sample is taken before discharge home from the initial neonatal hospitalization (at a postnatal age of up to 4-5 months at the most in very preterm infants)

Secondary

MeasureTime frame
concentrations of choline metabolitesat times when a clinically indicated blood sample is taken before discharge home from the initial neonatal hospitalization (at a postnatal age of up to 4-5 months at the most in very preterm infants)
Concentrations of molecular species of phosphatidylcholine and phosphatidylethanolamineat times when a clinically indicated blood sample is taken before discharge home from the initial neonatal hospitalization (at a postnatal age of up to 4-5 months at the most in very preterm infants)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026